Radiance Technologies (Radiance), an employee-owned leader in defense and intelligence solutions, has been awarded a prime Other Transaction (OT) contract valued up to $5.85 million over 18 months by ...

Biotech stock Oruka Therapeutics skyrocketed Wednesday on promising test results for what could be a once-annual shot to ...

The move comes amid other Big Pharma companies pledging to expand their U.S. manufacturing capacity to offset tariffs on ...

The desert sun scorched, with daytime temperatures hitting 40C as they measured data and adjusted water and fertilizer, sweat ...

Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...

Aditum’s newly formed biotech, dubbed Kalexo Bio, will develop the asset for patients with elevated cholesterol, or dyslipidemia, and for the prevention of high-risk atherosclerotic cardiovascular ...

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Good morning. Today, former CDC officials will testify before the Senate health committee about the recent upheaval at the ...

In a late-stage trial, an investigational GLP-1 pill from Eli Lilly helped diabetes patients lower their blood sugar and ...

Colossal Biosciences Inc., a biotechnology startup working to resurrect extinct animals, has raised $120 million from ...

A new biotech startup developing breakthrough vision treatments has sparked investor interest. The company, whose CEO has a ton of expertise in the field, has already inked drug licensing deals and ...

Some of Sanofi’s most high-profile readouts this year can’t have made for easy reading at the French pharma’s Paris ...